Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Indication

Pancreatic Carcinoma Metastatic

2 clinical trials

3 products

Product
Tusamitamab
Clinical trial
Open-label, Multi-cohort, Phase 2 Trial, Evaluating the Efficacy and Safety of Tusamitamab Ravtansine (SAR408701) Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors
Status: Active (not recruiting), Estimated PCD: 2024-08-30
Product
Gemcitabine
Clinical trial
A Randomized Double Blind Study of Pancreatic Enzyme Replacement Therapy for Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Status: Recruiting, Estimated PCD: 2024-11-30
Product
Pertzye